{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T04:00:03Z","timestamp":1754193603313,"version":"3.41.0"},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,6,15]]},"DOI":"10.2169\/internalmedicine.5254-25","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T22:09:33Z","timestamp":1743804573000},"page":"1867-1871","source":"Crossref","is-referenced-by-count":1,"title":["Severe COVID-19-related Pneumonia Seven Years after Heart Transplantation"],"prefix":"10.2169","volume":"64","author":[{"given":"Gentaro","family":"Taniguchi","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouji","family":"Matsushima","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Fujino","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Japan"},{"name":"Department of Advanced Cardiopulmonary Failure, Graduate School of Medical Sciences, Kyushu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Shinohara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kisanuki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayo","family":"Misumi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Katsuki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Shiose","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Graduate School of Medical Sciences, Kyushu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohtaro","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. NasrAllah MM, Osman NA, Elalfy M, Malvezzi P, Rostaing L. Transplantation in the era of the Covid-19 pandemic: how should transplant patients and programs be handled? Rev Med Virol 31: 1-9, 2021.","DOI":"10.1002\/rmv.2149"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hyams C, Challen R, Marlow R, et al. Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: a prospective cohort study in Bristol, United Kingdom. Lancet Reg Health Eur 25: 100556, 2023.","DOI":"10.1101\/2022.06.29.22277044"},{"key":"3","unstructured":"3. Yamanaga S, Shimata K, Ohfuji S, et al. Excess mortality in COVID-19-affected solid organ transplant recipients across the pandemic. Am J Transplant 24: 1495-1508, 2024."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bae S, Alejo JL, Chiang TPY, et al. mTOR inhibitors, mycophenolates, and other immunosuppression regimens on antibody response to SARS-CoV-2 mRNA vaccines in solid organ transplant recipients. Am J Transplant 22: 3137-3142, 2022.","DOI":"10.1111\/ajt.17158"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Zong K, Peng D, Yang H, et al. Risk factors for weak antibody response of SARS-CoV-2 vaccine in adult solid organ transplant recipients: a systemic review and meta-analysis. Front Immunol 13: 888385, 2022.","DOI":"10.3389\/fimmu.2022.888385"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Martens T, Hens L, De Pauw M, Van Belleghem Y. Heart transplantation complicated by COVID-19 infection. Ann Thorac Surg 113: e267-e269, 2022.","DOI":"10.1016\/j.athoracsur.2021.07.003"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hazan F, Verdonk C, Coutance G, et al. Severity of SARS-CoV-2 Omicron variant infection in heart transplant recipients. J Heart Lung Transplant 42: 558-561, 2023.","DOI":"10.1016\/j.healun.2023.01.012"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hedvat J, Lange NW, Salerno DM, et al. COVID-19 therapeutics and outcomes among solid organ transplant recipients during the Omicron BA.1 era. Am J Transplant 22: 2682-2688, 2022.","DOI":"10.1111\/ajt.17140"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Sharma S, Ruiz J, Nativi J, Patel P, Leoni J, Goswami R. The 90-day risk of hospitalization in heart transplant recipients after COVID-19 infection. Transplant Proc 56: 1496-1501, 2024.","DOI":"10.1016\/j.transproceed.2024.05.024"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Rayner DG, Nunes JT, Gou D, et al. Efficacy and safety of COVID-19 vaccination in solid organ transplant recipients: a systematic review and network meta-analysis. Am J Transplant 24: 2269-2281, 2024.","DOI":"10.1016\/j.ajt.2024.07.031"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kugler S, V\u00e1ri DK, Veres DS, et al. Seroconversion after SARS-CoV-2 vaccination is protective against severe COVID-19 disease in heart transplant recipients. Immun Inflamm Dis 11: e1086, 2023.","DOI":"10.1002\/iid3.1086"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Annema C, De Smet S, Castle EM, et al.; the ESOT Guidelines Taskforce. European Society of Organ Transplantation (ESOT) consensus statement on prehabilitation for solid organ transplantation candidates. Transpl Int 36: 11564, 2023.","DOI":"10.3389\/ti.2023.11564"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kawazoe M, Aoki K, Hirose W, Masuoka S, Nanki T. Influence of immunosuppressive therapy on longitudinal changes in anti-SARS-CoV-2 spike protein antibodies after two doses of mRNA vaccines in patients with rheumatic diseases. Eur J Intern Med 113: 111-113, 2023.","DOI":"10.1016\/j.ejim.2023.04.008"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Li G, Hilgenfeld R, Whitley R, De Clercq E. Therapeutic strategies for COVID-19: progress and lessons learned. Nat Rev Drug Discov 22: 449-475, 2023.","DOI":"10.1038\/s41573-023-00672-y"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Troxel AB, Petkova E, Goldfeld K, et al. Association of convalescent plasma treatment with clinical status in patients hospitalized with COVID-19: a meta-analysis. JAMA Netw Open 5: e2147331, 2022.","DOI":"10.1001\/jamanetworkopen.2021.47331"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Raman B, Bluemke DA, Luscher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J 43: 1157-1172, 2022.","DOI":"10.1093\/eurheartj\/ehac031"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. MacKay M, Tomcho JC, Khalife W. The impact of COVID-19 infection on heart transplant function. Bull Natl Res Cent 47: 1-9, 2023.","DOI":"10.1186\/s42269-023-01100-2"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Soares MN, Eggelbusch M, Naddaf E, et al. Skeletal muscle alterations in patients with acute Covid-19 and post-acute sequelae of Covid-19. J Cachexia Sarcopenia Muscle 13: 11-22, 2022.","DOI":"10.1002\/jcsm.12896"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Aschman T, Schneider J, Greuel S, et al. Association between SARS-CoV-2 infection and immune-mediated myopathy in patients who have died. JAMA Neurol 78: 948-960, 2021.","DOI":"10.1001\/jamaneurol.2021.2004"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Shi Z, de Vries HJ, Vlaar APJ, et al.; the Dutch COVID-19 Diaphragm Investigators. Diaphragm pathology in critically ill patients with COVID-19 and postmortem findings from 3 medical centers. JAMA Intern Med 181: 122-124, 2021.","DOI":"10.1001\/jamainternmed.2020.6278"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/12\/64_5254-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:00:47Z","timestamp":1750478447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/12\/64_5254-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,15]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5254-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,6,15]]},"article-number":"5254-25"}}